Velakor Biotherapeutics is developing CAM-6019, a novel Agrin-derived biologic therapy designed to promote cardiac regeneration and repair following heart attack and heart failure. By reactivating natural regenerative pathways inspired by the neonatal cardiac extracellular matrix, CAM-6019 aims to improve healing and restore heart function, with promising results demonstrated in large-animal models of ischemic heart disease